Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thomssen

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Haematology|April 1, 1989
Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disordersE J Battegay, C Thomssen, C Nissen, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|June 1, 1996
[Postpartum rupture of an aneurysm of the arteria lienalis]M Rust, J Schneider, B von Hundelshausen, et al.
Blood|November 1, 1989
Defective monocyte-to-macrophage maturation in patients with aplastic anemiaR Andreesen, W Brugger, C Thomssen, et al.
Anti-Cancer Drugs|October 1, 1995
Pattern of carboplatin-induced emesis. The German Ondansetron Study GroupA du Bois, W Vach, U Cramer-Giraud, et al.
Cancer Research|May 15, 1994
Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1F Jänicke, L Pache, M Schmitt, et al.
Onkologie|July 17, 2001
Clinical relevance of the plasminogen activator inhibitor type 1--a multifaceted proteolytic factorN Harbeck, A Krüger, S Sinz, et al.
Gynecologic Oncology|October 31, 2006
Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancerH G Strauss, A Henze, A Teichmann, et al.
Seminars in Oncology|November 28, 1997
Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancerH J Lück, C Thomssen, A du Bois, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Comparison of the emetogenic potential between cisplatin and carboplatin in combination with alkylating agentsA du Bois, W Vach, C Thomssen, et al.
Oncology (Williston Park, N.Y.)|April 1, 1997
Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancerH J Lück, A Du Bois, C Thomssen, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Haematology|April 1, 1989
Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disordersE J Battegay, C Thomssen, C Nissen, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|June 1, 1996
[Postpartum rupture of an aneurysm of the arteria lienalis]M Rust, J Schneider, B von Hundelshausen, et al.
Blood|November 1, 1989
Defective monocyte-to-macrophage maturation in patients with aplastic anemiaR Andreesen, W Brugger, C Thomssen, et al.
Anti-Cancer Drugs|October 1, 1995
Pattern of carboplatin-induced emesis. The German Ondansetron Study GroupA du Bois, W Vach, U Cramer-Giraud, et al.
Cancer Research|May 15, 1994
Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1F Jänicke, L Pache, M Schmitt, et al.
Onkologie|July 17, 2001
Clinical relevance of the plasminogen activator inhibitor type 1--a multifaceted proteolytic factorN Harbeck, A Krüger, S Sinz, et al.
Gynecologic Oncology|October 31, 2006
Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancerH G Strauss, A Henze, A Teichmann, et al.
Seminars in Oncology|November 28, 1997
Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancerH J Lück, C Thomssen, A du Bois, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Comparison of the emetogenic potential between cisplatin and carboplatin in combination with alkylating agentsA du Bois, W Vach, C Thomssen, et al.
Oncology (Williston Park, N.Y.)|April 1, 1997
Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancerH J Lück, A Du Bois, C Thomssen, et al.
Pageof 8